Deprescribing Cholinesterase Inhibitors and Memantine Deprescribing Cholinesterase Inhibitors and Memantine

The first evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine should lessen clinicians ' , patients ' , and families ' fear of discontinuing these agents.Medscape Family Medicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care Article Source Type: news
More News: Health | Namenda | Primary Care